EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL - Belgium 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2015-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 12
As coordinator: 3
As participant: 9
Sole participant: 0
Coordinator / Participant Ratio: 0.33*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 10.607.311 583.000 1
2022 0 14.866.441 638.895 1
2021 2.281.840 10.459.997 564.745 1 1
2020 0 18.000.000 300.000 1
2019 17.830.000 64.714.606 8.123.186 1 2
2018 0 6.000.000 200.000 1
2017 12.000.000 20.200.000 1.341.601 1 1
2015 0 5.996.992 580.500 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ABBVIE INC4
BAYER4
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM4
KATHOLIEKE UNIVERSITEIT LEUVEN4
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
JANSSEN PHARMACEUTICA NV3
LEIDS UNIVERSITAIR MEDISCH CENTRUM3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
PFIZER LIMITED3
STICHTING KATHOLIEKE UNIVERSITEIT3
TTOPSTART BV3
UNIVERSITA DEGLI STUDI DI TORINO3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY OF LEEDS3
ACADEMISCH ZIEKENHUIS GRONINGEN2
AMGEN2
ARTTIC INNOVATION2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
ASSOCIATION EISBM2
BAYER PHARMA2
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM2
CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD2
CENTRE DE REGULACIO GENOMICA2
EATRIS ERIC2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL2
EUROPEAN CANCER PATIENT COALITION2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
GMV SOLUCIONES GLOBALES INTERNET SAU2
HELMHOLTZZENTRUM DRESDENROSSENDORF EV2
INFRAFRONTIER2
INSTITUT CURIE2
INSTITUT GUSTAVE ROUSSY2
ISTITUTO EUROPEO DI ONCOLOGIA2
ISTITUTO SUPERIORE DI SANITA2
KING'S COLLEGE LONDON2
LUND UNIVERSITY2
MEDIZINISCHE UNIVERSITAT INNSBRUCK2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE2
OSLO UNIVERSITETSSYKEHUS HF2
OWKIN FRANCE2
REGION HOVEDSTADEN2
SANOFIAVENTIS2
STICHTING EUROPEAN UROLOGICAL FOUNDATION2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
STICHTING VUMC2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
THE UNIVERSITY OF MANCHESTER2
UNIVERSIDAD POLITECNICA DE MADRID2
UNIVERSITA VITASALUTE SAN RAFFAELE2
UNIVERSITAET BERN2
UNIVERSITAETSKLINIKUM FREIBURG2
UNIVERSITY OF ABERDEEN2
UNIVERSITY OF BIRMINGHAM2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UNIVERSITY OF TAMPERE2
UNIVERSITY OF YORK2
WEIZMANN INSTITUTE OF SCIENCE2
ABBVIE DEUTSCHLAND GMBH & CO KG1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACIBADEM MEHMET ALI AYDINLAR UNIVERSITY1
ADELPHI VALUES1
AGENCE NATIONALE DE LA RECHERCHE1
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
AGENDIA NV1
AGES OSTERREICHISCHE AGENTUR FUR GESUNDHEIT UND ERNAHRUNGSSICHERHEIT1
ALLEANZA CONTRO IL CANCRO1
ANTAROS MEDICAL AB1
ASS FRANCAISE CONTRE LES MYOPATHIES1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA1
AUSTRIAN RESEARCH CENTERS SIEBERDORF1
AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA1
AZIENDA OSPEDALIERA UNIVERSITARIA SENESE1
AZIENDA OSPEDALIERO UNIVERSITARIA PISANA1
AZIENDA SANITARIA UNIVERSITARIA FRIULI CENTRALE1
BARTS AND THE LONDON NHS TRUST1
BELGIAN NUCLEAR RESEARCH CENTRE1
BIOXYDYN LIMITED1
BLACKSWAN FOUNDATION1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BRUKER BIOSPIN MRI1
BUNDESAMT FUER STRAHLENSCHUTZ1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
CANADIAN INSTITUTES OF HEALTH RESEARCH1
CANCER INTELLIGENCE LIMITED1
CELGENE MANAGEMENT SARL1
CENTRE D'ETUDE SUR L'EVALUATION DE LA PROTECTION DANS LE DOMAINE NUCLEAIRE1
CENTRE DE RECHERCHE PUBLIC DE LA SANTE1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CENTRE SCIENTIFIQUE ET TECHNIQUE DU BATIMENT1
CENTRO DE INVESTIGACION BIOMEDICA EN RED1
CENTRO DE INVESTIGACIONES ENERGETICAS MEDIOAMBIENTALES Y TECNOLOGICAS1

Constancy:

Total number of partners: 415
Partner loyalty:
Frequent Partner: (> 2 projects): 52
Rare Partner: 363
Frequent / Rare Partner Ratio: 0.14

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe EUonQoLparticipant10.607.31127
2022-09-01Providing cutting edge cancer research services across Europe canSERVparticipant14.866.44118
2021-10-01Optimal treatment for patients with solid tumours in Europe through Artificial intelligence OPTIMAparticipant10.459.99739
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIcoordinator2.281.84033
2020-09-01Towards effective radiation protection based on improved scientific evidence and social considerations - focus on radon and NORM RadoNormparticipant18.000.00060
2019-03-01Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts IMMUcancoordinator17.830.00028
2019-01-01Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe HTxparticipant9.640.77515
2019-01-01European Joint Programme on Rare Diseases EJP RDparticipant55.073.83188
2018-05-01Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope PIONEERparticipant6.000.00034
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANcoordinator12.000.00021
2015-10-01Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor) MoTriColorparticipant5.996.99211